Control of motor coordination by astrocytic tonic GABA release through modulation of excitation/inhibition balance in cerebellum
J Woo, JO Min, DS Kang, YS Kim… - Proceedings of the …, 2018 - National Acad Sciences
Tonic inhibition in the brain is mediated through an activation of extrasynaptic GABAA
receptors by the tonically released GABA, resulting in a persistent GABAergic inhibitory …
receptors by the tonically released GABA, resulting in a persistent GABAergic inhibitory …
[HTML][HTML] Angelman syndrome: from mouse models to therapy
DC Rotaru, EJ Mientjes, Y Elgersma - Neuroscience, 2020 - Elsevier
The UBE3A gene is part of the chromosome 15q11-q13 region that is frequently deleted or
duplicated, leading to several neurodevelopmental disorders (NDD). Angelman syndrome …
duplicated, leading to several neurodevelopmental disorders (NDD). Angelman syndrome …
[HTML][HTML] Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse …
Angelman syndrome (AS) is a rare genetic and neurological disorder presenting with
seizures, developmental delay, ataxia, and lack of speech. Previous studies have indicated …
seizures, developmental delay, ataxia, and lack of speech. Previous studies have indicated …
[HTML][HTML] Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis
MS Sidorov, GM Deck, M Dolatshahi, RL Thibert… - Journal of …, 2017 - Springer
Background Clinicians have qualitatively described rhythmic delta activity as a prominent
EEG abnormality in individuals with Angelman syndrome, but this phenotype has yet to be …
EEG abnormality in individuals with Angelman syndrome, but this phenotype has yet to be …
[HTML][HTML] Electrophysiological phenotype in Angelman syndrome differs between genotypes
J Frohlich, MT Miller, LM Bird, P Garces, H Purtell… - Biological …, 2019 - Elsevier
Background Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by
either disruptions of the gene UBE3A or deletion of chromosome 15 at 15q11-q13, which …
either disruptions of the gene UBE3A or deletion of chromosome 15 at 15q11-q13, which …
[HTML][HTML] Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
D Hong, LM Iakoucheva - Translational Psychiatry, 2023 - nature.com
The past decade has yielded much success in the identification of risk genes for Autism
Spectrum Disorder (ASD), with many studies implicating loss-of-function (LoF) mutations …
Spectrum Disorder (ASD), with many studies implicating loss-of-function (LoF) mutations …
Allelic specificity of Ube3a expression in the mouse brain during postnatal development
MC Judson, JO Sosa‐Pagan… - Journal of …, 2014 - Wiley Online Library
Genetic alterations of the maternal UBE3A allele result in Angelman syndrome (AS), a
neurodevelopmental disorder characterized by severe developmental delay, lack of speech …
neurodevelopmental disorder characterized by severe developmental delay, lack of speech …
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Y Elgersma, M Sonzogni - Developmental Medicine & Child …, 2021 - Wiley Online Library
Half a century ago, Harry Angelman reported three patients with overlapping clinical
features, now well known as Angelman syndrome. Angelman syndrome is caused by …
features, now well known as Angelman syndrome. Angelman syndrome is caused by …
Adult Ube3a gene reinstatement restores the electrophysiological deficits of prefrontal cortex layer 5 neurons in a mouse model of Angelman syndrome
DC Rotaru, GM van Woerden, I Wallaard… - Journal of …, 2018 - Soc Neuroscience
E3 ubiquitin ligase (UBE3A) levels in the brain need to be tightly regulated, as loss of
functional UBE3A protein is responsible for the severe neurodevelopmental disorder …
functional UBE3A protein is responsible for the severe neurodevelopmental disorder …